Omics of Rituximab-resistance

Clinical trial NCT07416942 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07416942
Sponsor: Mario Negri Institute for Pharmacological Research
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Membranous Nephropathy

Start date: 2026-04-01
Primary completion: 2029-03-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.